Biopharmaceutical company MindMed has announced the first topline data from a novel Phase 2 trial testing high doses of LSD as a treatment for anxiety.

A leading artificial intelligence researcher lays out a new approach to AI that will enable us to coexist successfully with increasingly intelligent machines.

Part One: The Feds. A small group of regulators out West tests out a new theory of corporate enforcement, with disastrous consequences.

For the sixth year in a row, the number of U.S. births fell in 2020, reaching the lowest level since 1979. The fertility rate remains "below replacement" — the level needed to compensate for deaths.